Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05820906
Status:
RECRUITING
Last Update Posted:
2023-12-06
First Post:
2023-04-07
Brief Title:
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Organization Data
Organization:
Tianjin Medical University Cancer Institute and Hospital
Class:
OTHER
Study ID:
AK104-IIT-C-N1-0057
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
HuiKai Li
Responsible Party Title:
Professor and Chief Surgeon
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tianjin Medical University Cancer Institute and Hospital
Old Name:
None
Old Organization:
None